Prostate Radiotherapy May Increase Bladder Cancer Risk
Patients with prostate cancer who undergo radiation treatment, especially brachytherapy, may be at increased risk of bladder cancer more than 10 years later, according to the results of a new study presented at the American Urological Association annual meeting.
BeBRCAware
ONS Strategic Sponsor Approximately 15 percent of woman with ovarian cancer have a BRCA mutation and every year, many patients with ovarian cancer are not tested for a BRCA mutation. Family history and age are poor predictors of BRCA status in ovarian cancer patients, which is why it is so important for all women with ovarian cancer to be tested. BeBRCAware is a movement to raise awareness about the importance of genetic testing for a BRCA mutation in ovarian cancer.
ONS Attends Cancer Moonshot Summit; Blue Ribbon Panel Works Toward Final Report; ONS Comments on MIPS, APM
- Read more about ONS Attends Cancer Moonshot Summit; Blue Ribbon Panel Works Toward Final Report; ONS Comments on MIPS, APM
- Add new comment
Cancer Moonshot Summit Kicked Off in DC
June 29, 2016, marked the first official Cancer Moonshot Summit in Washington, DC. Hosted by Vice President Joe Biden, the summit brought together the nation’s leading oncology experts, researchers, healthcare professionals, survivors, private industry professionals and more. Many from the cancer community convened in DC with the hopes of advancing progress towards a cure.
What Oncology Nurses Should Know About the Zika Virus
Zika disease (ZIKV) is a viral infection spread to humans primarily through the Aedes species of mosquito. ZIKV can also be passed through sexual conduct and vertical transmission from mother to fetus during pregnancy. In February 2016, the World Health Organization declared the spread of ZIKV to be a public health emergency, citing clusters of neurologic-related conditions and birth defects corresponding with geographical outbreaks of the illness.
Quality Measures May Lengthen Survival in NSCLC
Researchers have found that four quality measures (neoadjuvant multiagent chemotherapy, lobectomy or greater resection, sampling of at least 10 lymph nodes, and R0 resection) are associated with longer survival in patients with stage IIIA non-small cell lung cancer.
Three Innovative Ways Technology Will Shift the Landscape of Cancer Care
- Read more about Three Innovative Ways Technology Will Shift the Landscape of Cancer Care
- Add new comment
Promote Cancer Prevention in the Face of Cancer Treatment
Maintaining and restoring health through the promotion of disease screening and early detection is a vital part of nursing. That role becomes no less important after a cancer diagnosis. Patients with cancer remain at risk for other malignancies, and that risk may even increase depending on treatment regimens.
Checkpoint Inhibitors May Cause Pseudoprogression and Dose-Limiting Side Effects
- Read more about Checkpoint Inhibitors May Cause Pseudoprogression and Dose-Limiting Side Effects
- Add new comment